US President Donald Trump's press briefing at the Oval office on lowering weight-loss drug prices after announcing a deal with drugmakers Eli Lilly and Novo Nordisk , ended abruptly after a pharma executive collapsed suddenly.

The executive who was standing near President Donald Trump's desk, collapsed during the start of Eli Lilly CEO Dave Ricks’ speech. He was identified as Novo Nordisk’s Gordon Findlay, said reports.

The press meet, which was televised, was cancelled immediately, before it got resumed again.

The pharma executive was later examined by Mehmet Oz, Trump's administrator for the Centers for Medicare and Medicaid Services, who said he was okay.

"During the most favored nations Oval Office announcement, a representative with one of the companies fainted. The white hous

See Full Page